Streetbeat News

Price Targets

SPRB

Over the past quarter, Spruce Biosciences (NASDAQ:SPRB) received 4 analyst ratings, with 2 being bullish and 2 somewhat bullish. There were no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for SPRB is $9.25, with a high of $10.00 and a low of $8.00. This target has increased by 208.33% over the past month. Analyst ratings are based on future earnings predictions and company risk assessments, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

GGB

B of A Securities has downgraded Gerdau (NYSE:GGB) from its previous rating to Neutral, adjusting the price target from $5.60 to $5.10. Gerdau's shares have fallen 2.31% in the last 24 hours to $4.81. The new price target suggests a potential upside of 6.03% from the current price. Gerdau is a steel producer with operations primarily in Brazil, but also in North America and South America, and specializes in various steel products.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

PENN

Penn Entertainment's stock is trading higher following an upgrade from B of A Securities, which changed its rating from Neutral to Buy and increased the price target from $27 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 5:00 pm

IIIV

Stephens & Co. has maintained its Overweight rating on i3 Verticals (NASDAQ:IIIV) but reduced its price target from $32.00 to $28.00. Despite the reduction, the new target suggests a significant 41.13% upside from the current price of $19.84. i3 Verticals provides integrated payment and software solutions, primarily generating revenue from its Proprietary Software and Payments segment.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

FOUR

Mizuho has maintained its Buy rating for Shift4 Payments (NYSE:FOUR) but reduced its price target from $80.00 to $75.00. Shift4 Payments' shares are currently trading at $64.09, down 0.85% over the last 24 hours. The new price target suggests a potential upside of 17.02% from the current price. Shift4 Payments provides integrated payment processing and technology solutions, catering to a variety of merchants and industries.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

BJ

Evercore ISI Group has maintained its In-Line rating for BJ's Wholesale Club (NYSE:BJ) but lowered its price target from $68.00 to $64.00. BJ's shares are currently trading at $64.30, and the new target suggests a slight decrease of 0.47%. BJ's Wholesale Club operates warehouse clubs and gas stations, offering a variety of products and generating revenue primarily from merchandise sales.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 5:00 pm

MSFT

Evercore ISI Group analyst Kirk Materne has reiterated an Outperform rating on Microsoft (NASDAQ:MSFT) and maintained a price target of $432.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:50 pm

GMAB

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Genmab (NASDAQ:GMAB) and maintained a $49 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:42 pm

CAKE

Wedbush analyst Nick Setyan has reiterated a Neutral rating on Cheesecake Factory (NASDAQ:CAKE) and maintained a $32 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:40 pm

TCON

HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on TRACON Pharmaceuticals (NASDAQ:TCON) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:37 pm